Swiss National Bank’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-40,438
| Closed | -$477K | – | 2716 |
|
|
2022
Q3 | $477K | Hold |
40,438
| – | – | ﹤0.01% | 2587 |
|
|
2022
Q2 | $457K | Hold |
40,438
| – | – | ﹤0.01% | 2633 |
|
|
2022
Q1 | $1.21M | Buy |
40,438
+3,190
| +9% | +$95.4K | ﹤0.01% | 2312 |
|
|
2021
Q4 | $987K | Hold |
37,248
| – | – | ﹤0.01% | 2484 |
|
|
2021
Q3 | $1.35M | Hold |
37,248
| – | – | ﹤0.01% | 2282 |
|
|
2021
Q2 | $1.62M | Sell |
37,248
-1,020
| -3% | -$44.3K | ﹤0.01% | 2241 |
|
|
2021
Q1 | $1.31M | Hold |
38,268
| – | – | ﹤0.01% | 2237 |
|
|
2020
Q4 | $1.34M | Hold |
38,268
| – | – | ﹤0.01% | 2146 |
|
|
2020
Q3 | $918K | Hold |
38,268
| – | – | ﹤0.01% | 2126 |
|
|
2020
Q2 | $700K | Buy |
38,268
+6,190
| +19% | +$113K | ﹤0.01% | 2285 |
|
|
2020
Q1 | $500K | Hold |
32,078
| – | – | ﹤0.01% | 2178 |
|
|
2019
Q4 | $686K | Buy |
32,078
+1,070
| +3% | +$22.9K | ﹤0.01% | 2311 |
|
|
2019
Q3 | $580K | Hold |
31,008
| – | – | ﹤0.01% | 2309 |
|
|
2019
Q2 | $809K | Buy |
31,008
+3,050
| +11% | +$79.6K | ﹤0.01% | 2230 |
|
|
2019
Q1 | $719K | Hold |
27,958
| – | – | ﹤0.01% | 2250 |
|
|
2018
Q4 | $643K | Buy |
27,958
+840
| +3% | +$19.3K | ﹤0.01% | 2240 |
|
|
2018
Q3 | $870K | Hold |
27,118
| – | – | ﹤0.01% | 2220 |
|
|
2018
Q2 | $767K | Buy |
27,118
+4,158
| +18% | +$118K | ﹤0.01% | 2310 |
|
|
2018
Q1 | $813K | Hold |
22,960
| – | – | ﹤0.01% | 2190 |
|
|
2017
Q4 | $891K | Buy |
+22,960
| New | +$891K | ﹤0.01% | 2155 |
|
|
2014
Q4 | – | Sell |
-9,160
| Closed | -$178K | – | 2579 |
|
|
2014
Q3 | $178K | Hold |
9,160
| – | – | ﹤0.01% | 2455 |
|
|
2014
Q2 | $333K | Sell |
9,160
-1,090
| -11% | -$39.6K | ﹤0.01% | 2350 |
|
|
2014
Q1 | $398K | Buy |
10,250
+2,700
| +36% | +$105K | ﹤0.01% | 2225 |
|
|
2013
Q4 | $215K | Hold |
7,550
| – | – | ﹤0.01% | 2377 |
|
|
2013
Q3 | $270K | Sell |
7,550
-700
| -8% | -$25K | ﹤0.01% | 2265 |
|
|
2013
Q2 | $276K | Buy |
+8,250
| New | +$276K | ﹤0.01% | 2252 |
|